Here, we review a case series of pediatric and adolescent patients, with de novo AML/MDS, harboring BCOR/BCORL1 mutations, adding to the growing body of research investigating the role of BCOR and BCORL1 mutations in pediatric myeloid malignancies. Here, BCORL1 is linked to myeloid neoplasm.